Skip to main content
CLBCore Laboratories Inc.Sell4.9·$11.69-0.93%
SellModerate Confidence
Investment thesis

Core Laboratories offers an attractive valuation and strong cash conversion, but declining revenue, a failed momentum gate, and justified elevated short interest reflect real near-term operating headwinds.

Thesis pillars

  • Earnings Beat Streak CatalystStable
  • Attractive Valuation Strong Cash ConversionStable
  • Declining Revenue And Failed MomentumImproving
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Core Laboratories Inc. (CLB) Stock Analysis

Recovery setup

SellVALUE-TRAP 1/5ShortModerate Confidence

Energy · Oil & Gas Equipment & Services

Earnings in 5 days (2026-07-29). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. At $11.69, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings in 5 days (event risk); Weak overall score: 4.9/10.

We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major,... Read more

$11.69+12.7% A.UpsideScore 4.9/10#33 of 37 Oil & Gas Equipment & Services
QualityF-score7 / 9FCF yield8.13%
IncomeYield0.33%(5y avg 0.22%)Payout6.56%sustainable
Stop $10.87Target $13.17(analyst − 15%)A.R:R 1.3:1
Analyst target$15.50+32.6%3 analysts
$13.17our TP
$11.69price
$15.50mean
$22

Sell if holding. At $11.69, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings in 5 days (event risk); Weak overall score: 4.9/10. Chart setup: Death cross but MACD improving, RSI 61. Score 4.9/10, moderate confidence.

Passes 6/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 5d<=7d. Suitability: speculative.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 29, 20265d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Risks
Earnings in 5 days (event risk)
Weak overall score: 4.9/10
Weak growth

Key Metrics

P/E (TTM)19.7
P/E (Fwd)17.5
Mkt Cap$544M
EV/EBITDA11.5
Profit Mgn5.5%
ROE11.1%
Rev Growth-1.4%
Beta1.01
Dividend0.33%
Rating analysts10

Quality Signals

Piotroski F7/9

Options Flow

P/C1.00neutral
IV77%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
1.5
Bollinger
2.2
Support Resistance
3.4
Gap
5.0

Revenue shrinking — -1.4% YoY. Growth thesis broken unless recovery story develops.static

Revenue Growth
2.1
Earnings Growth
4.5
Declining revenue: -1%
GatesA.R:R 1.3 < 1.5@spotEARNINGS PROXIMITY 5d<=7dDeath cross (50MA < 200MA)Momentum 5.5>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Speculative
RSI
61 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $10.57Resistance $12.27

Price Targets

$11
$13
A.Upside+12.7%
A.R:R1.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! asymmetry at 1.3 (below the engine's 1.5 threshold)@spot
! EARNINGS_PROXIMITY:5d<=7d

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (5d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLB stock a buy right now?

Sell if holding. At $11.69, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Earnings in 5 days (event risk); Weak overall score: 4.9/10. Chart setup: Death cross but MACD improving, RSI 61. Prior stop was $10.87. Score 4.9/10, moderate confidence.

What is the CLB stock price target?

Take-profit target: $13.17 (+12.7% upside). Prior stop was $10.87. Stop-loss: $10.87.

What are the risks of investing in CLB?

Earnings in 5 days (event risk); Weak overall score: 4.9/10; Weak growth.

Is CLB overvalued or undervalued?

Core Laboratories Inc. trades at a P/E of 19.7 (forward 17.5). TrendMatrix value score: 6.5/10. Verdict: Sell.

What do analysts say about CLB?

10 analysts cover CLB with a consensus score of 2.4/5. Average price target: $16.

What does Core Laboratories Inc. do?We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir...

We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major, national and independent oil companies. These services and products can enable our clients to evaluate and improve reservoir performance and increase oil and gas recovery from their new and existing fields.

Related stocks: FLOC (Flowco Holdings Inc.) · WHD (Cactus, Inc. Class A Common Sto) · NGS (Natural Gas Services Group, Inc) · USAC (USA Compression Partners, LP) · NESR (National Energy Services Reunit)
Home Stocks CLB

Latest news

No recent news